Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy.
By E. Jeyarajah, W. Cromwell, J. Otvos. Clinics in Laboratory Medicine, 2006
741 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging, Surgery
View Paper: https://www.semanticscholar.org/paper/2f1026b38a48c8cfdd9d53badd2fa033baa8d52b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Surgery
Citations in the corpus
- Dysfunctional Adiposity and the Risk of Prediabetes and Type 2 Diabetes in Obese Adults (2012, methodology): “magnetic resonance spectroscopy.(27) In DHS-2, standard laboratory assays were used to measure cholesterol and glucose, and HbA1c was measured using an Ultra-2 affinity high-performance liquid chromatography assay (Trinity Biotech).”
- A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk (2011, methodology): “We attempted to identify all published reports that reported risk estimates of non-HDL-C and apoB, relying on 4 sources: (1) the ERFC study,6 (2) a literature search based on PubMed for articles published since 2005 containing both apoB and non-HDL-C as key words; (3) a meta-analysis by Thompson and”